Doripenem: a new, potent, broad-spectrum treatment for serious Gram-negative infections

被引：0
|
作者：
Naber, K.
机构：
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2007年 / 29卷
关键词：
D O I：
10.1016/S0924-8579(07)70191-7
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S59 / S60
页数：2
相关论文
共 50 条
  • [41] EFFICACY AND SAFETY OF AZTREONAM IN THE TREATMENT OF SERIOUS GRAM-NEGATIVE BACTERIAL-INFECTIONS
    LEFROCK, JL
    SMITH, BR
    CHANDRASEKAR, P
    ROLSTON, KVI
    MOLAVI, A
    KANNANGARA, W
    ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (02) : 325 - 328
  • [42] Doripenem Monohydrate, A Broad-Spectrum Carbapenem Antibiotic
    Matthews, S. James
    Lancaster, Jason W.
    CLINICAL THERAPEUTICS, 2009, 31 (01) : 42 - 63
  • [43] Pyridone Methylsulfone Hydroxamate LpxC Inhibitors for the Treatment of Serious Gram-Negative Infections
    Montgomery, Justin I.
    Brown, Matthew F.
    Reilly, Usa
    Price, Loren M.
    Abramite, Joseph A.
    Arcari, Joel
    Barham, Rose
    Che, Ye
    Chen, Jinshan Michael
    Chung, Seung Won
    Collantes, Elizabeth M.
    Desbonnet, Charlene
    Doroski, Matthew
    Doty, Jonathan
    Enrakul, Juntyma J.
    Harris, Thomas M.
    Huband, Michael
    Knafels, John D.
    Leach, Karen L.
    Liu, Shenping
    Marfat, Anthony
    McAllister, Laura
    McElroy, Eric
    Menard, Carol A.
    Mitton-Fry, Mark
    Mullins, Lisa
    Noe, Mark C.
    O'Donnell, John
    Oliver, Robert
    Penzien, Joseph
    Plummer, Mark
    Shanmugasundaram, Veerabahu
    Thoma, Christy
    Tomaras, Andrew P.
    Uccello, Daniel P.
    Vaz, Alfin
    Wishka, Donn G.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (04) : 1662 - 1670
  • [44] Which Gram-Negative Antibiotic Complements Vancomycin for Broad-Spectrum Coverage of Endophthalmitis: Amikacin or Ceftazidime?
    Kodati, Shilpa
    Eller, Andrew W.
    Kowalski, Regis P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [45] PIPERACILLIN AND GENTAMICIN V CARBENICILLIN AND GENTAMICIN FOR TREATMENT OF SERIOUS GRAM-NEGATIVE INFECTIONS
    KOHLER, RB
    FOERSTER, LA
    WHEAT, LJ
    WILLIAMS, JM
    REYNOLDS, J
    NORTON, J
    ARCHIVES OF INTERNAL MEDICINE, 1982, 142 (07) : 1335 - 1337
  • [46] Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections
    Matt Shirley
    Drugs, 2018, 78 : 675 - 692
  • [47] Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections
    Shirley, Matt
    DRUGS, 2018, 78 (06) : 675 - 692
  • [48] EMERGENCE OF RESISTANCE IN GRAM-NEGATIVE BACTERIA - A RISK OF BROAD-SPECTRUM BETA-LACTAM USE
    DWORZACK, DL
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1986, 20 (7-8): : 562 - 567
  • [49] Reduction in broad-spectrum Gram-negative agents by diverse prescribing of aztreonam within NHS Tayside
    Kennedy, Heather
    Wilson, Sarah
    Marwick, Charis
    Malcolm, William
    Nathwani, Dilip
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (08) : 2421 - 2423
  • [50] Does broad-spectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?
    Nordmann, Patrice
    Poirel, Laurent
    Toleman, Mark A.
    Walsh, Timothy R.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (04) : 689 - 692
12345